81 – 90 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Mature T-cell lymphoma patients show high relapse rates after high dose therapy followed by autologous transplantation
2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.113-114(
- Contribution to journal › Published meeting abstract
-
Mark
Burkitt's lymphoma: Comparison of 2 nationwide population-based lymphoma registries
2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.131-131(
- Contribution to journal › Published meeting abstract
-
Mark
Sox11, a non-B cell lineage transcription factor, is overexpressed in mantle cell lymphoma
2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.172-173(
- Contribution to journal › Published meeting abstract
-
Mark
Nordic Observational Study Evaluating Safety And Analgesic Use In Patients With Advanced Cancer Under Zoledronic Acid Treatment Interim Analysis
(
- Contribution to journal › Published meeting abstract
-
Mark
a multicentre, phase ii study of cp-4055 in combination with sorafenib in patients with metastatic malignant melanoma
(
- Contribution to journal › Published meeting abstract
-
Mark
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
(
- Contribution to journal › Article
-
Mark
Familial characteristics of Waldenström's macroglobulinemia (WM) and lymphoplasmacytic lymphoma (LPL): A population-based study in Sweden
2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.166-166(
- Contribution to journal › Published meeting abstract
-
Mark
Self-selection in sigmoidoscopy screening: A nine-year follow-up study
(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy
(
- Contribution to journal › Article
-
Mark
Targeted therapy in nuclear medicine current status and future prospects
(
- Contribution to journal › Article